For: | Tan GH, Huang FY, Wang H, Huang YH, Lin YY, Li YN. Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World J Gastroenterol 2007; 13(17): 2479-2483 [PMID: 17552032 DOI: 10.3748/wjg.v13.i17.2479] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2479.htm |
Number | Citing Articles |
1 |
E. Fonsatti, H. J.M. Nicolay, M. Altomonte, A. Covre, M. Maio. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovascular Research 2010; 86(1): 12 doi: 10.1093/cvr/cvp332
|
2 |
Dafne Müller, Gerhard Trunk, Anke Sichelstiel, Kirstin A. Zettlitz, Miguel Quintanilla, Roland E. Kontermann. Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice. Journal of Immunological Methods 2008; 339(1): 90 doi: 10.1016/j.jim.2008.08.008
|
3 |
Pia Vihinen, Risto Ala-aho, Veli-Matti Kähäri. Diagnostic and prognostic role of matrix metalloproteases in cancer. Expert Opinion on Medical Diagnostics 2008; 2(9): 1025 doi: 10.1517/17530059.2.9.1025
|
4 |
Monika Stimac, Tanja Dolinsek, Ursa Lampreht, Maja Cemazar, Gregor Sersa, Ilya Ulasov. Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects. PLOS ONE 2015; 10(4): e0124913 doi: 10.1371/journal.pone.0124913
|
5 |
Aldona Kasprzak, Agnieszka Adamek. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy. International Journal of Molecular Sciences 2018; 19(12): 3887 doi: 10.3390/ijms19123887
|
6 |
Sun Young Kim, You Sun Kim, Hyun Tae Kim, Sun Ok Kwon, Myoung Ki Oh, In Hye Cha, Kyeong Sam Ok, Cheol Hun Kwak, Jin Nam Kim, Jeong Seop Moon. A Prospective Study of Factors Influencing on the Clinical Characteristics of Colonic Diverticulosis. The Korean Journal of Gastroenterology 2013; 62(2): 97 doi: 10.4166/kjg.2013.62.2.97
|